WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AXSM past revenue growth

How has AXSM's revenue growth performed historically?
Company
440.8%
Industry
144.63%
Market
17.55%
AXSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AXSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AXSM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AXSM earnings and revenue history

Current Revenue
$270.6M
Current Earnings
-$239.2M
Current Profit Margin
-88.4%

AXSM Return on Equity

Current Company
-112.4%
Current Industry
-63.5%
Current Market
188%
AXSM's Return on Equity (-112.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AXSM announces earnings.

AXSM Return on Assets

Current Company
-43.7%
Current Industry
2.9%
AXSM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AXSM Return on Capital Employed

Current Company
-51.59%
Current Industry
19.5%
AXSM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AXSM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AXSM$270.60M-$223.54M-$239.24M+440.80%N/A
SWTX$5.45M-$321.78M-$325.10M-94.52%N/A
IOVA$1.19M-$414.39M-$444.04MN/AN/A
FTRE$3.11B$194.70M-$3.40M+58.95%N/A
BHVN$0.00-$402.64M-$408.17MN/AN/A
View Top Biotech Stocks

AXSM earnings dates

Next earnings date
Jun 7, 2024

Axsome Therapeutics Earnings & Revenue FAQ

What were AXSM's earnings last quarter?

On Invalid Date, Axsome Therapeutics (NASDAQ: AXSM) reported Q4 2023 earnings per share (EPS) of -$2.13, up 48.95% year over year. Total Axsome Therapeutics earnings for the quarter were -$98.65 million. In the same quarter last year, Axsome Therapeutics's earnings per share (EPS) was -$1.43.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.

What was AXSM's earnings growth in the past year?

As of Q2 2024, Axsome Therapeutics's earnings has grown year over year. Axsome Therapeutics's earnings in the past year totalled -$239.24 million.

What is AXSM's earnings date?

Axsome Therapeutics's earnings date is Invalid Date. Add AXSM to your watchlist to be reminded of AXSM's next earnings announcement.

What was AXSM's revenue last quarter?

On Invalid Date, Axsome Therapeutics (NASDAQ: AXSM) reported Q4 2023 revenue of $71.53 million up 193.5% year over year. In the same quarter last year, Axsome Therapeutics's revenue was $24.37 million.

What was AXSM's revenue growth in the past year?

As of Q2 2024, Axsome Therapeutics's revenue has grown 440.8% year over year. This is 296.17 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Axsome Therapeutics's revenue in the past year totalled $270.60 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.